Cargando…
Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions
Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expand also beyond high grade gliomas. However, a significant number of recurrences and resistance to the drug is observed. The key factor in each chemotherapy is to achieve the therapeutic doses of a drug...
Autores principales: | Belter, Agnieszka, Barciszewski, Jakub, Barciszewska, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043761/ https://www.ncbi.nlm.nih.gov/pubmed/32101575 http://dx.doi.org/10.1371/journal.pone.0229534 |
Ejemplares similares
-
Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line
por: Barciszewska, Anna-Maria, et al.
Publicado: (2023) -
Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines
por: Barciszewska, Anna-Maria, et al.
Publicado: (2022) -
A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells
por: Barciszewska, Anna-Maria, et al.
Publicado: (2015) -
Inhibition of miR-21 in glioma cells using catalytic nucleic acids
por: Belter, Agnieszka, et al.
Publicado: (2016) -
The Sequence and Structure Determine the Function of Mature Human miRNAs
por: Rolle, Katarzyna, et al.
Publicado: (2016)